Maxime Dougados

The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection

Martín Rudwaleit, Désirée van der Heijde, R. B. M. Landewé et al. · Annals of the Rheumatic Diseases · 2009 · 3.6K citations · Full text

Medicine, Radiology, Musculoskeletal Medicine +11

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update

Josef S Smolen, Robert Landewé, Ferdinand C. Breedveld et al. · Annals of the Rheumatic Diseases · 2013 · 1.8K citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +15

The Assessment of SpondyloArthritis international Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general

Martín Rudwaleit, D. van der Heijde, R. B. M. Landewé et al. · Annals of the Rheumatic Diseases · 2010 · 1.7K citations · Full text

Medicine, Dermatology, Internal Medicine +16

Rituximab for rheumatoid arthritis refractory to anti–tumor necrosis factor therapy: Results of a multicenter, randomized, double‐blind, placebo‐controlled, phase III trial evaluating primary efficacy and safety at twenty‐four weeks

Stanley Cohen, Paul Emery, Maria Greenwald et al. · Arthritis & Rheumatism · 2006 · 1.6K citations

Medicine, Pharmacology, Pharmacotherapy +16

Abatacept for Rheumatoid Arthritis Refractory to Tumor Necrosis Factor α Inhibition

Mark C. Genovese, Jean‐Claude Becker, Michael Schiff et al. · New England Journal of Medicine · 2005 · 1.2K citations · Full text

Pharmacy, Immunology, Pharmacotherapy +16